Resurrect Bio

Resurrect Bio
Developing disease-resistant crops using AI-driven platform to resurrect native resistance mechanisms.
About
What does Resurrect Bio do?
Resurrect Bio is a London-based agricultural BioTech startup focused on developing disease-resistant crops. They leverage an AI-driven platform to resurrect complex, native disease resistance mechanisms within crops, offering a sustainable alternative to chemical crop protection. The company aims to become a leading provider of plant disease resistance solutions for the seed industry, collaborating with seed companies and breeders to bring durable resistance traits to market faster than conventi…
What is Resurrect Bio's revenue?
StartupHub estimates Resurrect Bio's annual revenue at $832K (range $241K to $3.3M, 34% confidence), based on comparable companies in the sector.
What is Resurrect Bio's valuation?
StartupHub estimates Resurrect Bio's effective valuation at $41.0M (range $25.8M to $61.8M, 23% confidence), based on comparable companies in the sector.
How much funding has Resurrect Bio raised?
Resurrect Bio has raised a total of $10M in funding. The most recent round on record is Series A.
Where is Resurrect Bio headquartered?
Resurrect Bio is headquartered in London, England, United Kingdom.
When was Resurrect Bio founded?
Resurrect Bio was founded in 2022.
What industry does Resurrect Bio operate in?
Resurrect Bio operates in Biotechnology, Agriculture, Artificial Intelligence, Agritech, AgTech, Biotech.
Galatek develops AI-driven automation solutions for life sciences laboratories and advanced semiconductor manufacturing, focusing on precision and reproducibility.
Digital batch record software for pharmaceutical and biotech manufacturing.
Develops and commercializes treatments for central nervous system disorders, including Rett syndrome.
A deep-tech company developing nanorobotic solutions for healthcare, initially targeting dental care applications.
MatrixCode is a research focus at the Freiburg Institute for Advanced Studies (FRIAS) investigating matrisome pathology.
A company focused on privacy, Zcash accumulation, and developing cancer therapeutics.
An entrant is a company tagged Biotechnology whose domain was first registered in the window, counted from registry records in the StartupHub directory. Registry detection runs two to three weeks behind registration, so recent weeks are a floor.
No comments yet. Be the first to share your take.
